HRTS · Tema Heart & Health ETF ETF
Tema ETF Trust
$37.57
-1.02%
At close · Sep 4
Net assets $51,915,425
Holdings35
1 month
+0.82%
Year to date
+6.46%
52-week range
$29.54–$38.87
30-session avg volume
5,584
Market performance
Adjusted close · up to five years
Fund profile
- Structure
- Exchange-traded product
- SEC series
- S000081541
- Report date
- May 31, 2026
- Holdings coverage
- Tracked U.S. equities
Portfolio concentration
Top 10 holdings—
Calculated only when the SEC filing is stored with complete portfolio coverage.
Portfolio holdings
Latest linked SEC Form NPORT-P report.
| Holding | Ticker / CUSIP | Value | Weight |
|---|---|---|---|
| Eli Lilly & Co | LLY | $5,981,365 | 11.52% |
| UnitedHealth Group Inc | UNH | $2,722,639 | 5.24% |
| Merck & Co Inc | MRK | $2,216,740 | 4.27% |
| Thermo Fisher Scientific Inc | TMO | $2,061,154 | 3.97% |
| Johnson & Johnson | JNJ | $1,864,380 | 3.59% |
| Gilead Sciences Inc | GILD | $1,782,676 | 3.43% |
| Revolution Medicines Inc | RVMD | $1,727,713 | 3.33% |
| Vertex Pharmaceuticals Inc | VRTX | $1,520,741 | 2.93% |
| Danaher Corp | DHR | $1,380,437 | 2.66% |
| Abbott Laboratories | ABT | $1,353,250 | 2.61% |
| Bridgebio Pharma Inc | BBIO | $1,346,867 | 2.59% |
| Cytokinetics Inc | CYTK | $1,310,216 | 2.52% |
| AbbVie Inc | ABBV | $1,244,052 | 2.40% |
| Bristol-Myers Squibb Co | BMY | $1,082,932 | 2.09% |
| Teva Pharmaceutical Industries | TEVA | $1,069,242 | 2.06% |
| Dexcom Inc | DXCM | $996,375 | 1.92% |
| Amgen Inc | AMGN | $992,183 | 1.91% |
| Edwards Lifesciences Corp | EW | $906,897 | 1.75% |
| McKesson Corp | MCK | $887,958 | 1.71% |
| Regeneron Pharmaceuticals Inc | REGN | $865,610 | 1.67% |
| Madrigal Pharmaceuticals Inc | MDGL | $755,353 | 1.45% |
| Boston Scientific Corp | BSX | $738,418 | 1.42% |
| Intuitive Surgical Inc | ISRG | $675,178 | 1.30% |
| Alnylam Pharmaceuticals Inc | ALNY | $590,069 | 1.14% |
| Arrowhead Pharmaceuticals Inc | ARWR | $564,068 | 1.09% |
| Scholar Rock Holding Corp | SRRK | $475,597 | 0.92% |
| Xenon Pharmaceuticals Inc | XENE | $459,349 | 0.88% |
| Ionis Pharmaceuticals Inc | IONS | $428,324 | 0.83% |
| Insulet Corp | PODD | $410,905 | 0.79% |
| Insmed Inc | INSM | $368,733 | 0.71% |
| Stoke Therapeutics Inc | STOK | $310,615 | 0.60% |
| Viking Therapeutics Inc | VKTX | $279,534 | 0.54% |
| MBX Biosciences Inc | MBX | $275,709 | 0.53% |
| Intellia Therapeutics Inc | NTLA | $195,460 | 0.38% |
| Structure Therapeutics Inc | GPCR | $180,295 | 0.35% |